{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T22:12:37Z","timestamp":1795039957865,"version":"4.10.2"},"reference-count":101,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,2,7]],"date-time":"2025-02-07T00:00:00Z","timestamp":1738886400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,2,7]],"date-time":"2025-02-07T00:00:00Z","timestamp":1738886400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cardiovasc Diabetol"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>The rising prevalence of obesity and its association with heart failure with preserved ejection fraction (HFpEF) highlight an urgent need for a diagnostic approach tailored to this population. Diagnosing HFpEF is hampered by the lack of a single non-invasive diagnostic criterion. While this makes a firm diagnosis of HFpEF already notoriously difficult in the general population, it is even more challenging in individuals with obesity. The challenges stem from a range of factors, including the use of body mass index as a conceptually suboptimal indicator of health risks associated with increased body mass, symptom overlap between HFpEF and obesity, limitations in physical examination, difficulties in electrocardiographic and echocardiographic evaluation, and reduced diagnostic sensitivity of natriuretic peptides in individuals with obesity. In this review, we examine these diagnostic challenges and propose a diagnostic algorithm specifically tailored to improve the accuracy and reliability of HFpEF diagnosis in this growing patient demographic.<\/jats:p>\n                  <jats:p>\n                    <jats:bold>Graphical abstract<\/jats:bold>\n                  <\/jats:p>\n                  <jats:p>Proposed obesity-adjusted HFpEF score. HFpEF, Heart failure with preserved ejection fraction. Created with BioRender.com.<\/jats:p>","DOI":"10.1186\/s12933-025-02612-z","type":"journal-article","created":{"date-parts":[[2025,2,7]],"date-time":"2025-02-07T09:35:10Z","timestamp":1738920910000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":40,"title":["Challenges in the diagnosis of heart failure with preserved ejection fraction in individuals with obesity"],"prefix":"10.1186","volume":"24","author":[{"given":"Bas M.","family":"van Dalen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie Fen","family":"Chin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Praveen A.","family":"Motiram","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anneke","family":"Hendrix","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mireille E.","family":"Emans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jasper J.","family":"Brugts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B. Daan","family":"Westenbrink","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rudolf A.","family":"de Boer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,2,7]]},"reference":[{"key":"2612_CR1","unstructured":"Obesity and overweight fact sheet World Health Organization. [Available from: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/obesity-and-overweight"},{"issue":"19","key":"2612_CR2","doi-asserted-by":"publisher","first-page":"1424","DOI":"10.1093\/eurheartj\/eht066","volume":"34","author":"FP Brouwers","year":"2013","unstructured":"Brouwers FP, de Boer RA, van der Harst P, Voors AA, Gansevoort RT, Bakker SJ, et al. Incidence and epidemiology of new onset heart failure with preserved vs. reduced ejection fraction in a community-based cohort: 11-year follow-up of PREVEND. Eur Heart J. 2013;34(19):1424\u201331.","journal-title":"Eur Heart J"},{"issue":"2","key":"2612_CR3","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1161\/CIRCHEARTFAILURE.112.972828","volume":"6","author":"JE Ho","year":"2013","unstructured":"Ho JE, Lyass A, Lee DS, Vasan RS, Kannel WB, Larson MG, et al. Predictors of new-onset heart failure: differences in preserved versus reduced ejection fraction. Circ Heart Fail. 2013;6(2):279\u201386.","journal-title":"Circ Heart Fail"},{"issue":"2","key":"2612_CR4","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/j.jacc.2016.05.019","volume":"68","author":"DW Kitzman","year":"2016","unstructured":"Kitzman DW, Shah SJ. The HFpEF obesity phenotype: the elephant in the room. J Am Coll Cardiol. 2016;68(2):200\u20133.","journal-title":"J Am Coll Cardiol"},{"issue":"9","key":"2612_CR5","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1016\/j.jacc.2016.11.081","volume":"69","author":"A Pandey","year":"2017","unstructured":"Pandey A, LaMonte M, Klein L, Ayers C, Psaty BM, Eaton CB, et al. Relationship between physical activity, body mass index, and risk of heart failure. J Am Coll Cardiol. 2017;69(9):1129\u201342.","journal-title":"J Am Coll Cardiol"},{"issue":"12","key":"2612_CR6","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1016\/j.jchf.2018.07.009","volume":"6","author":"VN Rao","year":"2018","unstructured":"Rao VN, Zhao D, Allison MA, Guallar E, Sharma K, Criqui MH, et al. Adiposity and incident heart failure and its subtypes: MESA (multi-ethnic study of atherosclerosis). JACC Heart Fail. 2018;6(12):999\u20131007.","journal-title":"JACC Heart Fail"},{"issue":"3","key":"2612_CR7","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1161\/CIRCHEARTFAILURE.110.959890","volume":"4","author":"M Haass","year":"2011","unstructured":"Haass M, Kitzman DW, Anand IS, Miller A, Zile MR, Massie BM, et al. Body mass index and adverse cardiovascular outcomes in heart failure patients with preserved ejection fraction: results from the Irbesartan in Heart failure with preserved ejection fraction (I-PRESERVE) trial. Circ Heart Fail. 2011;4(3):324\u201331.","journal-title":"Circ Heart Fail"},{"issue":"8","key":"2612_CR8","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1016\/j.jchf.2018.05.018","volume":"6","author":"N Savji","year":"2018","unstructured":"Savji N, Meijers WC, Bartz TM, Bhambhani V, Cushman M, Nayor M, et al. The association of obesity and cardiometabolic traits with Incident HFpEF and HFrEF. JACC Heart Fail. 2018;6(8):701\u20139.","journal-title":"JACC Heart Fail"},{"issue":"40","key":"2612_CR9","doi-asserted-by":"publisher","first-page":"3297","DOI":"10.1093\/eurheartj\/ehz641","volume":"40","author":"B Pieske","year":"2019","unstructured":"Pieske B, Tschope C, de Boer RA, Fraser AG, Anker SD, Donal E, et al. How to diagnose heart failure with preserved ejection fraction: the HFA-PEFF diagnostic algorithm: a consensus recommendation from the Heart Failure Association (HFA) of the European Society of Cardiology (ESC). Eur Heart J. 2019;40(40):3297\u2013317.","journal-title":"Eur Heart J"},{"issue":"9","key":"2612_CR10","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1161\/CIRCULATIONAHA.118.034646","volume":"138","author":"YNV Reddy","year":"2018","unstructured":"Reddy YNV, Carter RE, Obokata M, Redfield MM, Borlaug BA. A simple, evidence-based approach to help guide diagnosis of heart failure with preserved ejection fraction. Circulation. 2018;138(9):861\u201370.","journal-title":"Circulation"},{"issue":"6","key":"2612_CR11","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1002\/ejhf.1494","volume":"21","author":"C Mueller","year":"2019","unstructured":"Mueller C, McDonald K, de Boer RA, Maisel A, Cleland JGF, Kozhuharov N, et al. Heart Failure Association of the European Society of Cardiology practical guidance on the use of natriuretic peptide concentrations. Eur J Heart Fail. 2019;21(6):715\u201331.","journal-title":"Eur J Heart Fail"},{"issue":"10026","key":"2612_CR12","doi-asserted-by":"publisher","first-page":"1377","DOI":"10.1016\/S0140-6736(16)30054-X","volume":"387","author":"NCDRF Collaboration","year":"2016","unstructured":"Collaboration NCDRF. Trends in adult body-mass index in 200 countries from 1975 to 2014: a pooled analysis of 1698 population-based measurement studies with 19.2 million participants. Lancet. 2016;387(10026):1377\u201396.","journal-title":"Lancet"},{"issue":"Suppl 3","key":"2612_CR13","doi-asserted-by":"publisher","first-page":"S56","DOI":"10.1038\/ijo.2008.87","volume":"32","author":"KJ Rothman","year":"2008","unstructured":"Rothman KJ. BMI-related errors in the measurement of obesity. Int J Obes (Lond). 2008;32(Suppl 3):S56\u20139.","journal-title":"Int J Obes (Lond)"},{"issue":"23","key":"2612_CR14","doi-asserted-by":"publisher","first-page":"2211","DOI":"10.1056\/NEJMoa1000367","volume":"363","author":"A Berrington de Gonzalez","year":"2010","unstructured":"Berrington de Gonzalez A, Hartge P, Cerhan JR, Flint AJ, Hannan L, MacInnis RJ, et al. Body-mass index and mortality among 1.46 million white adults. N Engl J Med. 2010;363(23):2211\u20139.","journal-title":"N Engl J Med"},{"issue":"10046","key":"2612_CR15","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1016\/S0140-6736(16)30175-1","volume":"388","author":"BMIMC Global","year":"2016","unstructured":"Global BMIMC, Di Angelantonio E, Bhupathiraju Sh N, Wormser D, Gao P, Kaptoge S, et al. Body-mass index and all-cause mortality: individual-participant-data meta-analysis of 239 prospective studies in four continents. Lancet. 2016;388(10046):776\u201386.","journal-title":"Lancet"},{"issue":"Suppl 2","key":"2612_CR16","doi-asserted-by":"publisher","first-page":"e13190","DOI":"10.1111\/obr.13190","volume":"22","author":"A Bosy-Westphal","year":"2021","unstructured":"Bosy-Westphal A, Muller MJ. Diagnosis of obesity based on body composition-associated health risks-time for a change in paradigm. Obes Rev. 2021;22(Suppl 2):e13190.","journal-title":"Obes Rev"},{"issue":"8","key":"2612_CR17","doi-asserted-by":"publisher","first-page":"1355","DOI":"10.1016\/j.amjcard.2016.01.033","volume":"117","author":"P Srikanthan","year":"2016","unstructured":"Srikanthan P, Horwich TB, Tseng CH. Relation of muscle mass and fat mass to cardiovascular disease mortality. Am J Cardiol. 2016;117(8):1355\u201360.","journal-title":"Am J Cardiol"},{"key":"2612_CR18","doi-asserted-by":"publisher","first-page":"e5900","DOI":"10.1136\/bmj.e5900","volume":"345","author":"A Abbasi","year":"2012","unstructured":"Abbasi A, Peelen LM, Corpeleijn E, van der Schouw YT, Stolk RP, Spijkerman AM, et al. Prediction models for risk of developing type 2 diabetes: systematic literature search and independent external validation study. BMJ. 2012;345:e5900.","journal-title":"BMJ"},{"key":"2612_CR19","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.ejim.2022.12.024","volume":"109","author":"N Suthahar","year":"2023","unstructured":"Suthahar N, Wang K, Zwartkruis VW, Bakker SJL, Inzucchi SE, Meems LMG, et al. Associations of relative fat mass, a new index of adiposity, with type-2 diabetes in the general population. Eur J Intern Med. 2023;109:73\u20138.","journal-title":"Eur J Intern Med"},{"issue":"1","key":"2612_CR20","doi-asserted-by":"publisher","first-page":"10980","DOI":"10.1038\/s41598-018-29362-1","volume":"8","author":"OO Woolcott","year":"2018","unstructured":"Woolcott OO, Bergman RN. Relative fat mass (RFM) as a new estimator of whole-body fat percentage horizontal line a cross-sectional study in American adult individuals. Sci Rep. 2018;8(1):10980.","journal-title":"Sci Rep"},{"issue":"7","key":"2612_CR21","doi-asserted-by":"publisher","first-page":"e39504","DOI":"10.1371\/journal.pone.0039504","volume":"7","author":"NY Krakauer","year":"2012","unstructured":"Krakauer NY, Krakauer JC. A new body shape index predicts mortality hazard independently of body mass index. PLoS ONE. 2012;7(7):e39504.","journal-title":"PLoS ONE"},{"issue":"11","key":"2612_CR22","doi-asserted-by":"publisher","first-page":"2264","DOI":"10.1002\/oby.20408","volume":"21","author":"DM Thomas","year":"2013","unstructured":"Thomas DM, Bredlau C, Bosy-Westphal A, Mueller M, Shen W, Gallagher D, et al. Relationships between body roundness with body fat and visceral adipose tissue emerging from a new geometrical model. Obes (Silver Spring). 2013;21(11):2264\u201371.","journal-title":"Obes (Silver Spring)"},{"issue":"1","key":"2612_CR23","doi-asserted-by":"publisher","first-page":"16753","DOI":"10.1038\/s41598-018-35073-4","volume":"8","author":"Y Park","year":"2018","unstructured":"Park Y, Kim NH, Kwon TY, Kim SG. A novel adiposity index as an integrated predictor of cardiometabolic disease morbidity and mortality. Sci Rep. 2018;8(1):16753.","journal-title":"Sci Rep"},{"issue":"1","key":"2612_CR24","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1038\/s41598-021-02409-6","volume":"12","author":"N Suthahar","year":"2022","unstructured":"Suthahar N, Meems LMG, Withaar C, Gorter TM, Kieneker LM, Gansevoort RT, et al. Relative fat mass, a new index of adiposity, is strongly associated with incident heart failure: data from PREVEND. Sci Rep. 2022;12(1):147.","journal-title":"Sci Rep"},{"issue":"142","key":"2612_CR25","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1183\/16000617.0081-2016","volume":"25","author":"V Bernhardt","year":"2016","unstructured":"Bernhardt V, Babb TG. Exertional dyspnoea in obesity. Eur Respir Rev. 2016;25(142):487\u201395.","journal-title":"Eur Respir Rev"},{"issue":"13","key":"2612_CR26","doi-asserted-by":"publisher","first-page":"1477","DOI":"10.1001\/archinte.162.13.1477","volume":"162","author":"DD Sin","year":"2002","unstructured":"Sin DD, Jones RL, Man SF. Obesity is a risk factor for dyspnea but not for airflow obstruction. Arch Intern Med. 2002;162(13):1477\u201381.","journal-title":"Arch Intern Med"},{"issue":"3","key":"2612_CR27","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1378\/chest.130.3.827","volume":"130","author":"RL Jones","year":"2006","unstructured":"Jones RL, Nzekwu MM. The effects of body mass index on lung volumes. Chest. 2006;130(3):827\u201333.","journal-title":"Chest"},{"issue":"6","key":"2612_CR28","doi-asserted-by":"publisher","first-page":"2217","DOI":"10.1152\/japplphysiol.00898.2006","volume":"102","author":"D Ofir","year":"2007","unstructured":"Ofir D, Laveneziana P, Webb KA, O\u2019Donnell DE. Ventilatory and perceptual responses to cycle exercise in obese women. J Appl Physiol (1985). 2007;102(6):2217\u201326.","journal-title":"J Appl Physiol (1985)"},{"issue":"4","key":"2612_CR29","doi-asserted-by":"publisher","first-page":"1236","DOI":"10.1152\/jappl.1998.85.4.1236","volume":"85","author":"W Pankow","year":"1998","unstructured":"Pankow W, Podszus T, Gutheil T, Penzel T, Peter J, Von Wichert P. Expiratory flow limitation and intrinsic positive end-expiratory pressure in obesity. J Appl Physiol (1985). 1998;85(4):1236\u201343.","journal-title":"J Appl Physiol (1985)"},{"key":"2612_CR30","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1152\/jappl.1960.15.3.377","volume":"15","author":"A Naimark","year":"1960","unstructured":"Naimark A, Cherniack RM. Compliance of the respiratory system and its components in health and obesity. J Appl Physiol. 1960;15:377\u201382.","journal-title":"J Appl Physiol"},{"issue":"4","key":"2612_CR31","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1172\/JCI104957","volume":"43","author":"JT Sharp","year":"1964","unstructured":"Sharp JT, Henry JP, Sweany SK, Meadows WR, Pietras RJ. The total work of breathing in normal and obese men. J Clin Invest. 1964;43(4):728\u201339.","journal-title":"J Clin Invest"},{"key":"2612_CR32","doi-asserted-by":"crossref","unstructured":"Witte J, Singh H, Turk Y, van Huisstede A, Birnie E, Hiemstra P et al. Effect of bariatric surgery on lung function and asthma control after 8 years of follow-up. Allergy Asthma Proc. 2023;44(3):165\u2013\u200970.","DOI":"10.2500\/aap.2023.44.230009"},{"issue":"3","key":"2612_CR33","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1111\/j.1467-789X.2006.00251.x","volume":"7","author":"SC Wearing","year":"2006","unstructured":"Wearing SC, Hennig EM, Byrne NM, Steele JR, Hills AP. Musculoskeletal disorders associated with obesity: a biomechanical perspective. Obes Rev. 2006;7(3):239\u201350.","journal-title":"Obes Rev"},{"key":"2612_CR34","doi-asserted-by":"crossref","unstructured":"Buckwalter JA, Saltzman C, Brown T. The impact of osteoarthritis: implications for research. Clin Orthop Relat Res. 2004(427 Suppl):S6\u201315.","DOI":"10.1097\/01.blo.0000143938.30681.9d"},{"key":"2612_CR35","first-page":"4","volume":"67","author":"L Lidgren","year":"2003","unstructured":"Lidgren L. The bone and joint decade and the global economic and healthcare burden of musculoskeletal disease. J Rheumatol Suppl. 2003;67:4\u20135.","journal-title":"J Rheumatol Suppl"},{"issue":"11","key":"2612_CR36","doi-asserted-by":"publisher","first-page":"1549","DOI":"10.1161\/CIRCRESAHA.119.315896","volume":"126","author":"H Wu","year":"2020","unstructured":"Wu H, Ballantyne CM. Metabolic inflammation and insulin resistance in obesity. Circ Res. 2020;126(11):1549\u201364.","journal-title":"Circ Res"},{"issue":"2","key":"2612_CR37","first-page":"93","volume":"50","author":"AM Prentice","year":"1996","unstructured":"Prentice AM, Black AE, Coward WA, Cole TJ. Energy expenditure in overweight and obese adults in affluent societies: an analysis of 319 doubly-labelled water measurements. Eur J Clin Nutr. 1996;50(2):93\u20137.","journal-title":"Eur J Clin Nutr"},{"key":"2612_CR38","doi-asserted-by":"crossref","unstructured":"Mendelson M, Marillier M, Bailly S, Flore P, Borel JC, Vivodtzev I et al. Maximal exercise capacity in patients with obstructive sleep apnoea syndrome: a systematic review and meta-analysis. Eur Respir J. 2018;51(6).","DOI":"10.1183\/13993003.02697-2017"},{"key":"2612_CR39","doi-asserted-by":"publisher","first-page":"1296433","DOI":"10.3389\/fpsyt.2024.1296433","volume":"15","author":"D Kocol","year":"2024","unstructured":"Kocol D, Bauerle A, Schadendorf T, Geiger S, Krakowczyk JB, Skoda EM, et al. Efficacy of eHealth interventions to reduce depression symptoms in individuals with obesity: a systematic review of randomized controlled trials. Front Psychiatry. 2024;15:1296433.","journal-title":"Front Psychiatry"},{"issue":"3","key":"2612_CR40","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1001\/archgenpsychiatry.2010.2","volume":"67","author":"FS Luppino","year":"2010","unstructured":"Luppino FS, de Wit LM, Bouvy PF, Stijnen T, Cuijpers P, Penninx BW, et al. Overweight, obesity, and depression: a systematic review and meta-analysis of longitudinal studies. Arch Gen Psychiatry. 2010;67(3):220\u20139.","journal-title":"Arch Gen Psychiatry"},{"issue":"18","key":"2612_CR41","doi-asserted-by":"publisher","first-page":"3434","DOI":"10.1093\/cvr\/cvac120","volume":"118","author":"BA Borlaug","year":"2023","unstructured":"Borlaug BA, Jensen MD, Kitzman DW, Lam CSP, Obokata M, Rider OJ. Obesity and heart failure with preserved ejection fraction: new insights and pathophysiological targets. Cardiovasc Res. 2023;118(18):3434\u201350.","journal-title":"Cardiovasc Res"},{"issue":"1","key":"2612_CR42","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1161\/CIRCULATIONAHA.116.026807","volume":"136","author":"M Obokata","year":"2017","unstructured":"Obokata M, Reddy YNV, Pislaru SV, Melenovsky V, Borlaug BA. Evidence supporting the existence of a distinct obese phenotype of heart failure with preserved ejection fraction. Circulation. 2017;136(1):6\u201319.","journal-title":"Circulation"},{"key":"2612_CR43","doi-asserted-by":"crossref","unstructured":"Stencel J, Alai HR, Dhore-Patil A, Urina-Jassir D, Le Jemtel TH. Obesity, preserved ejection fraction heart failure, and left ventricular remodeling. J Clin Med. 2023;12(9).","DOI":"10.3390\/jcm12093341"},{"issue":"6","key":"2612_CR44","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1002\/ejhf.1788","volume":"22","author":"YNV Reddy","year":"2020","unstructured":"Reddy YNV, Rikhi A, Obokata M, Shah SJ, Lewis GD, AbouEzzedine OF, et al. Quality of life in heart failure with preserved ejection fraction: importance of obesity, functional capacity, and physical inactivity. Eur J Heart Fail. 2020;22(6):1009\u201318.","journal-title":"Eur J Heart Fail"},{"issue":"18","key":"2612_CR45","doi-asserted-by":"publisher","first-page":"1120","DOI":"10.12968\/bjon.2009.18.18.44557","volume":"18","author":"M Todd","year":"2009","unstructured":"Todd M. Managing chronic oedema in the morbidly obese patient. Br J Nurs. 2009;18(18):1120\u20134.","journal-title":"Br J Nurs"},{"issue":"9","key":"2612_CR46","doi-asserted-by":"publisher","first-page":"1247","DOI":"10.1038\/ijo.2010.273","volume":"35","author":"AM Vasileiou","year":"2011","unstructured":"Vasileiou AM, Bull R, Kitou D, Alexiadou K, Garvie NJ, Coppack SW. Oedema in obesity; role of structural lymphatic abnormalities. Int J Obes (Lond). 2011;35(9):1247\u201350.","journal-title":"Int J Obes (Lond)"},{"issue":"2","key":"2612_CR47","doi-asserted-by":"publisher","first-page":"148","DOI":"10.3122\/jabfm.19.2.148","volume":"19","author":"JW Ely","year":"2006","unstructured":"Ely JW, Osheroff JA, Chambliss ML, Ebell MH. Approach to leg edema of unclear etiology. J Am Board Fam Med. 2006;19(2):148\u201360.","journal-title":"J Am Board Fam Med"},{"key":"2612_CR48","unstructured":"Ferguson CM, Inspection. auscultation, palpation, and percussion of the abdomen. In: Walker HK, Hall WD, Hurst JW, editors. Clinical Methods: The History, Physical, and Laboratory Examinations. 3rd ed. Boston1990."},{"issue":"8","key":"2612_CR49","first-page":"330","volume":"74","author":"RC Oey","year":"2016","unstructured":"Oey RC, van Buuren HR, de Man RA. The diagnostic work-up in patients with ascites: current guidelines and future prospects. Neth J Med. 2016;74(8):330\u20135.","journal-title":"Neth J Med"},{"issue":"1","key":"2612_CR50","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/s44158-021-00019-2","volume":"1","author":"I Di Giacinto","year":"2021","unstructured":"Di Giacinto I, Guarnera M, Esposito C, Falcetta S, Cortese G, Pascarella G, et al. Emergencies in obese patients: a narrative review. J Anesth Analg Crit Care. 2021;1(1):13.","journal-title":"J Anesth Analg Crit Care"},{"issue":"4","key":"2612_CR51","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1111\/j.1742-6723.2010.01307.x","volume":"22","author":"J Kam","year":"2010","unstructured":"Kam J, Taylor DM. Obesity significantly increases the difficulty of patient management in the emergency department. Emerg Med Australas. 2010;22(4):316\u201323.","journal-title":"Emerg Med Australas"},{"issue":"2","key":"2612_CR52","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1001\/jama.2010.1950","volume":"305","author":"AW Silk","year":"2011","unstructured":"Silk AW, McTigue KM. Reexamining the physical examination for obese patients. JAMA. 2011;305(2):193\u20134.","journal-title":"JAMA"},{"issue":"4","key":"2612_CR53","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1111\/j.1467-789X.2005.00199.x","volume":"6","author":"MA Fraley","year":"2005","unstructured":"Fraley MA, Birchem JA, Senkottaiyan N, Alpert MA. Obesity and the electrocardiogram. Obes Rev. 2005;6(4):275\u201381.","journal-title":"Obes Rev"},{"issue":"7","key":"2612_CR54","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1016\/S0002-9149(99)00894-2","volume":"85","author":"MA Alpert","year":"2000","unstructured":"Alpert MA, Terry BE, Cohen MV, Fan TM, Painter JA, Massey CV. The electrocardiogram in morbid obesity. Am J Cardiol. 2000;85(7):908\u201310. A10.","journal-title":"Am J Cardiol"},{"issue":"2","key":"2612_CR55","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1378\/chest.119.2.507","volume":"119","author":"MA Alpert","year":"2001","unstructured":"Alpert MA, Terry BE, Hamm CR, Fan TM, Cohen MV, Massey CV, et al. Effect of weight loss on the ECG of normotensive morbidly obese patients. Chest. 2001;119(2):507\u201310.","journal-title":"Chest"},{"issue":"5","key":"2612_CR56","doi-asserted-by":"publisher","first-page":"2080","DOI":"10.1210\/jcem.87.5.8516","volume":"87","author":"GM Corbi","year":"2002","unstructured":"Corbi GM, Carbone S, Ziccardi P, Giugliano G, Marfella R, Nappo F, et al. FFAs and QT intervals in obese women with visceral adiposity: effects of sustained weight loss over 1 year. J Clin Endocrinol Metab. 2002;87(5):2080\u20133.","journal-title":"J Clin Endocrinol Metab"},{"issue":"14","key":"2612_CR57","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1016\/S0002-9149(99)80700-0","volume":"75","author":"A el-Gamal","year":"1995","unstructured":"el-Gamal A, Gallagher D, Nawras A, Gandhi P, Gomez J, Allison DB, et al. Effects of obesity on QT, RR, and QTc intervals. Am J Cardiol. 1995;75(14):956\u20139.","journal-title":"Am J Cardiol"},{"issue":"12","key":"2612_CR58","doi-asserted-by":"publisher","first-page":"1104","DOI":"10.1038\/sj.ijo.0800521","volume":"21","author":"JJ Park","year":"1997","unstructured":"Park JJ, Swan PD. Effect of obesity and regional adiposity on the QTc interval in women. Int J Obes Relat Metab Disord. 1997;21(12):1104\u201310.","journal-title":"Int J Obes Relat Metab Disord"},{"issue":"12","key":"2612_CR59","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1016\/0002-9149(94)90829-X","volume":"73","author":"MA Alpert","year":"1994","unstructured":"Alpert MA, Lambert CR, Terry BE, Kelly DL, Panayiotou H, Mukerji V, et al. Effect of weight loss on left ventricular mass in nonhypertensive morbidly obese patients. Am J Cardiol. 1994;73(12):918\u201321.","journal-title":"Am J Cardiol"},{"issue":"2","key":"2612_CR60","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1016\/S0002-8703(96)90360-9","volume":"131","author":"E Himeno","year":"1996","unstructured":"Himeno E, Nishino K, Nakashima Y, Kuroiwa A, Ikeda M. Weight reduction regresses left ventricular mass regardless of blood pressure level in obese subjects. Am Heart J. 1996;131(2):313\u20139.","journal-title":"Am Heart J"},{"issue":"10","key":"2612_CR61","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1016\/j.amjmed.2008.05.034","volume":"121","author":"EP Havranek","year":"2008","unstructured":"Havranek EP, Froshaug DB, Emserman CD, Hanratty R, Krantz MJ, Masoudi FA, et al. Left ventricular hypertrophy and cardiovascular mortality by race and ethnicity. Am J Med. 2008;121(10):870\u20135.","journal-title":"Am J Med"},{"key":"2612_CR62","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.ijcard.2018.09.104","volume":"276","author":"K Porthan","year":"2019","unstructured":"Porthan K, Kentta T, Niiranen TJ, Nieminen MS, Oikarinen L, Viitasalo M, et al. ECG left ventricular hypertrophy as a risk predictor of sudden cardiac death. Int J Cardiol. 2019;276:125\u20139.","journal-title":"Int J Cardiol"},{"issue":"6","key":"2612_CR63","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1111\/anec.12223","volume":"19","author":"L Bacharova","year":"2014","unstructured":"Bacharova L, Ugander M. Left ventricular hypertrophy: the relationship between the electrocardiogram and cardiovascular magnetic resonance imaging. Ann Noninvasive Electrocardiol. 2014;19(6):524\u201333.","journal-title":"Ann Noninvasive Electrocardiol"},{"issue":"3","key":"2612_CR64","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1016\/S0735-1097(85)80115-7","volume":"6","author":"PN Casale","year":"1985","unstructured":"Casale PN, Devereux RB, Kligfield P, Eisenberg RR, Miller DH, Chaudhary BS, et al. Electrocardiographic detection of left ventricular hypertrophy: development and prospective validation of improved criteria. J Am Coll Cardiol. 1985;6(3):572\u201380.","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"2612_CR65","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/0002-8703(49)90562-1","volume":"37","author":"M Sokolow","year":"1949","unstructured":"Sokolow M, Lyon TP. The ventricular complex in left ventricular hypertrophy as obtained by unipolar precordial and limb leads. Am Heart J. 1949;37(2):161\u201386.","journal-title":"Am Heart J"},{"issue":"8","key":"2612_CR66","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/S0895-7061(03)00912-9","volume":"16","author":"P Verdecchia","year":"2003","unstructured":"Verdecchia P, Angeli F, Reboldi G, Carluccio E, Benemio G, Gattobigio R, et al. Improved cardiovascular risk stratification by a simple ECG index in hypertension. Am J Hypertens. 2003;16(8):646\u201352.","journal-title":"Am J Hypertens"},{"issue":"6","key":"2612_CR67","doi-asserted-by":"publisher","first-page":"e12564","DOI":"10.1111\/anec.12564","volume":"23","author":"J Domienik-Karlowicz","year":"2018","unstructured":"Domienik-Karlowicz J, Rymarczyk Z, Lisik W, Kurnicka K, Ciurzynski M, Bielecki M, et al. Questionable validity of left ventricular hypertrophy cutoff values in morbidly and super-morbidly obese patients. Ann Noninvasive Electrocardiol. 2018;23(6):e12564.","journal-title":"Ann Noninvasive Electrocardiol"},{"issue":"1","key":"2612_CR68","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1007\/s40292-014-0062-3","volume":"22","author":"G Germano","year":"2015","unstructured":"Germano G. Electrocardiographic signs of left ventricular hypertrophy in obese patients: what criteria should be used? High Blood Press Cardiovasc Prev. 2015;22(1):5\u20139.","journal-title":"High Blood Press Cardiovasc Prev"},{"issue":"1","key":"2612_CR69","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/0735-1097(95)00421-1","volume":"27","author":"PM Okin","year":"1996","unstructured":"Okin PM, Roman MJ, Devereux RB, Kligfield P. Electrocardiographic identification of left ventricular hypertrophy: test performance in relation to definition of hypertrophy and presence of obesity. J Am Coll Cardiol. 1996;27(1):124\u201331.","journal-title":"J Am Coll Cardiol"},{"issue":"9","key":"2612_CR70","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1002\/clc.22560","volume":"39","author":"C Robinson","year":"2016","unstructured":"Robinson C, Woodiwiss AJ, Libhaber CD, Norton GR. Novel Approach to the detection of left ventricular hypertrophy using body mass index-corrected electrocardiographic voltage criteria in a Group of African Ancestry. Clin Cardiol. 2016;39(9):524\u201330.","journal-title":"Clin Cardiol"},{"issue":"3","key":"2612_CR71","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1016\/j.amjcard.2014.05.016","volume":"114","author":"F Angeli","year":"2014","unstructured":"Angeli F, Verdecchia P, Iacobellis G, Reboldi G. Usefulness of QRS voltage correction by body mass index to improve electrocardiographic detection of left ventricular hypertrophy in patients with systemic hypertension. Am J Cardiol. 2014;114(3):427\u201332.","journal-title":"Am J Cardiol"},{"issue":"5","key":"2612_CR72","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1002\/clc.23333","volume":"43","author":"SM Snelder","year":"2020","unstructured":"Snelder SM, van de Poll SWE, de Groot-de Laat LE, Kardys I, Zijlstra F, van Dalen BM. Optimized electrocardiographic criteria for the detection of left ventricular hypertrophy in obesity patients. Clin Cardiol. 2020;43(5):483\u201390.","journal-title":"Clin Cardiol"},{"issue":"2","key":"2612_CR73","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/j.hlc.2021.06.525","volume":"31","author":"K Ellenberger","year":"2022","unstructured":"Ellenberger K, Jeyaprakash P, Sivapathan S, Sangha S, Kitley J, Darshni A, et al. The effect of obesity on echocardiographic image quality. Heart Lung Circ. 2022;31(2):207\u201315.","journal-title":"Heart Lung Circ"},{"issue":"7","key":"2612_CR74","doi-asserted-by":"publisher","first-page":"1082","DOI":"10.1016\/j.amjcard.2005.10.052","volume":"97","author":"RS Finkelhor","year":"2006","unstructured":"Finkelhor RS, Moallem M, Bahler RC. Characteristics and impact of obesity on the outpatient echocardiography laboratory. Am J Cardiol. 2006;97(7):1082\u20134.","journal-title":"Am J Cardiol"},{"issue":"11","key":"2612_CR75","doi-asserted-by":"publisher","first-page":"1491","DOI":"10.1016\/j.echo.2019.07.019","volume":"32","author":"SM Snelder","year":"2019","unstructured":"Snelder SM, Younge JO, Dereci A, van Velzen JE, Akkerhuis JM, de Groot-de Laat LE, et al. Feasibility and reproducibility of transthoracic echocardiography in obese patients. J Am Soc Echocardiogr. 2019;32(11):1491\u20133. e5.","journal-title":"J Am Soc Echocardiogr"},{"issue":"2","key":"2612_CR76","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1002\/ejhf.2377","volume":"24","author":"M Obokata","year":"2022","unstructured":"Obokata M, Reddy YNV, Melenovsky V, Sorimachi H, Jarolim P, Borlaug BA. Uncoupling between intravascular and distending pressures leads to underestimation of circulatory congestion in obesity. Eur J Heart Fail. 2022;24(2):353\u201361.","journal-title":"Eur J Heart Fail"},{"issue":"3","key":"2612_CR77","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1093\/ehjci\/jev014","volume":"16","author":"RM Lang","year":"2015","unstructured":"Lang RM, Badano LP, Mor-Avi V, Afilalo J, Armstrong A, Ernande L, et al. Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. Eur Heart J Cardiovasc Imaging. 2015;16(3):233\u201370.","journal-title":"Eur Heart J Cardiovasc Imaging"},{"issue":"12","key":"2612_CR78","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.1016\/j.echo.2014.10.006","volume":"27","author":"G de Simone","year":"2014","unstructured":"de Simone G, Galderisi M. Allometric normalization of cardiac measures: producing better, but imperfect, accuracy. J Am Soc Echocardiogr. 2014;27(12):1275\u20138.","journal-title":"J Am Soc Echocardiogr"},{"issue":"1","key":"2612_CR79","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1007\/s10554-023-02981-0","volume":"40","author":"Y Aga","year":"2024","unstructured":"Aga Y, Acardag Y, Chin JF, Kroon D, Snelder SM, De Groot-De Laat L, et al. Improved identification of left atrial enlargement in patients with obesity. Int J Cardiovasc Imaging. 2024;40(1):65\u201372.","journal-title":"Int J Cardiovasc Imaging"},{"issue":"10","key":"2612_CR80","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1016\/j.echo.2021.05.009","volume":"34","author":"P Jeyaprakash","year":"2021","unstructured":"Jeyaprakash P, Moussad A, Pathan S, Sivapathan S, Ellenberger K, Madronio C, et al. A systematic review of scaling left atrial size: are alternative indexation methods required for an increasingly obese population? J Am Soc Echocardiogr. 2021;34(10):1067\u201376. e3.","journal-title":"J Am Soc Echocardiogr"},{"issue":"33","key":"2612_CR81","doi-asserted-by":"publisher","first-page":"3021","DOI":"10.1093\/eurheartj\/ehy339","volume":"39","author":"B Williams","year":"2018","unstructured":"Williams B, Mancia G, Spiering W, Agabiti Rosei E, Azizi M, Burnier M, et al. 2018 ESC\/ESH guidelines for the management of arterial hypertension. Eur Heart J. 2018;39(33):3021\u2013104.","journal-title":"Eur Heart J"},{"key":"2612_CR82","doi-asserted-by":"crossref","unstructured":"Nagueh SF, Smiseth OA, Appleton CP, Byrd BF 3rd, Dokainish H, Edvardsen T, et al. Recommendations for the evaluation of left ventricular diastolic function by Echocardiography: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. Eur Heart J Cardiovasc Imaging. 2016;17(12):1321\u201360.","DOI":"10.1093\/ehjci\/jew082"},{"issue":"4","key":"2612_CR83","doi-asserted-by":"publisher","first-page":"2345","DOI":"10.1002\/ehf2.14372","volume":"10","author":"YS Aga","year":"2023","unstructured":"Aga YS, Abou Kamar S, Chin JF, van den Berg VJ, Strachinaru M, Bowen D, et al. Potential role of left atrial strain in estimation of left atrial pressure in patients with chronic heart failure. ESC Heart Fail. 2023;10(4):2345\u201353.","journal-title":"ESC Heart Fail"},{"issue":"15","key":"2612_CR84","doi-asserted-by":"publisher","first-page":"1961","DOI":"10.1016\/j.jacc.2019.01.059","volume":"73","author":"L Thomas","year":"2019","unstructured":"Thomas L, Marwick TH, Popescu BA, Donal E, Badano LP. Left atrial structure and function, and left ventricular diastolic dysfunction: JACC state-of-the-art review. J Am Coll Cardiol. 2019;73(15):1961\u201377.","journal-title":"J Am Coll Cardiol"},{"issue":"5","key":"2612_CR85","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1016\/j.jcmg.2022.10.011","volume":"16","author":"SF Nagueh","year":"2023","unstructured":"Nagueh SF, Khan SU. Left atrial strain for assessment of left ventricular diastolic function: focus on populations with normal LVEF. JACC Cardiovasc Imaging. 2023;16(5):691\u2013707.","journal-title":"JACC Cardiovasc Imaging"},{"issue":"3","key":"2612_CR86","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1007\/s10554-022-02744-3","volume":"39","author":"YS Aga","year":"2023","unstructured":"Aga YS, Kroon D, Snelder SM, Biter LU, de Groot-de Laat LE, Zijlstra F, et al. Decreased left atrial function in obesity patients without known cardiovascular disease. Int J Cardiovasc Imaging. 2023;39(3):471\u20139.","journal-title":"Int J Cardiovasc Imaging"},{"issue":"9","key":"2612_CR87","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1161\/CIRCULATIONAHA.116.024822","volume":"135","author":"M Obokata","year":"2017","unstructured":"Obokata M, Kane GC, Reddy YN, Olson TP, Melenovsky V, Borlaug BA. Role of diastolic stress testing in the evaluation for heart failure with preserved ejection fraction: a simultaneous invasive-echocardiographic study. Circulation. 2017;135(9):825\u201338.","journal-title":"Circulation"},{"issue":"5","key":"2612_CR88","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1016\/j.ahj.2005.10.011","volume":"151","author":"LB Daniels","year":"2006","unstructured":"Daniels LB, Clopton P, Bhalla V, Krishnaswamy P, Nowak RM, McCord J, et al. How obesity affects the cut-points for B-type natriuretic peptide in the diagnosis of acute heart failure. Results from the Breathing not properly multinational study. Am Heart J. 2006;151(5):999\u20131005.","journal-title":"Am Heart J"},{"issue":"3","key":"2612_CR89","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1016\/j.ijcard.2014.08.007","volume":"176","author":"C Madamanchi","year":"2014","unstructured":"Madamanchi C, Alhosaini H, Sumida A, Runge MS. Obesity and natriuretic peptides, BNP and NT-proBNP: mechanisms and diagnostic implications for heart failure. Int J Cardiol. 2014;176(3):611\u20137.","journal-title":"Int J Cardiol"},{"issue":"8","key":"2612_CR90","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1002\/ejhf.1209","volume":"20","author":"N Suthahar","year":"2018","unstructured":"Suthahar N, Meijers WC, Ho JE, Gansevoort RT, Voors AA, van der Meer P, et al. Sex-specific associations of obesity and N-terminal pro-B-type natriuretic peptide levels in the general population. Eur J Heart Fail. 2018;20(8):1205\u201314.","journal-title":"Eur J Heart Fail"},{"issue":"9","key":"2612_CR91","doi-asserted-by":"publisher","first-page":"1545","DOI":"10.1002\/ejhf.2618","volume":"24","author":"N Kozhuharov","year":"2022","unstructured":"Kozhuharov N, Martin J, Wussler D, Lopez-Ayala P, Belkin M, Strebel I, et al. Clinical effect of obesity on N-terminal pro-B-type natriuretic peptide cut-off concentrations for the diagnosis of acute heart failure. Eur J Heart Fail. 2022;24(9):1545\u201354.","journal-title":"Eur J Heart Fail"},{"issue":"4","key":"2612_CR92","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1373\/clinchem.2009.129742","volume":"56","author":"RH Christenson","year":"2010","unstructured":"Christenson RH, Azzazy HM, Duh SH, Maynard S, Seliger SL, Defilippi CR. Impact of increased body mass index on accuracy of B-type natriuretic peptide (BNP) and N-terminal proBNP for diagnosis of decompensated heart failure and prediction of all-cause mortality. Clin Chem. 2010;56(4):633\u201341.","journal-title":"Clin Chem"},{"issue":"526","key":"2612_CR93","first-page":"327","volume":"56","author":"A Fuat","year":"2006","unstructured":"Fuat A, Murphy JJ, Hungin AP, Curry J, Mehrzad AA, Hetherington A, et al. The diagnostic accuracy and utility of a B-type natriuretic peptide test in a community population of patients with suspected heart failure. Br J Gen Pract. 2006;56(526):327\u201333.","journal-title":"Br J Gen Pract"},{"issue":"4","key":"2612_CR94","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1016\/j.ejheart.2005.01.022","volume":"7","author":"A Zaphiriou","year":"2005","unstructured":"Zaphiriou A, Robb S, Murray-Thomas T, Mendez G, Fox K, McDonagh T, et al. The diagnostic accuracy of plasma BNP and NTproBNP in patients referred from primary care with suspected heart failure: results of the UK natriuretic peptide study. Eur J Heart Fail. 2005;7(4):537\u201341.","journal-title":"Eur J Heart Fail"},{"issue":"3","key":"2612_CR95","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1002\/ejhf.2403","volume":"24","author":"AM Jackson","year":"2022","unstructured":"Jackson AM, Rorth R, Liu J, Kristensen SL, Anand IS, Claggett BL, et al. Diabetes and pre-diabetes in patients with heart failure and preserved ejection fraction. Eur J Heart Fail. 2022;24(3):497\u2013509.","journal-title":"Eur J Heart Fail"},{"issue":"5","key":"2612_CR96","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1016\/j.jacc.2018.11.033","volume":"73","author":"K McHugh","year":"2019","unstructured":"McHugh K, DeVore AD, Wu J, Matsouaka RA, Fonarow GC, Heidenreich PA, et al. Heart failure with preserved ejection fraction and diabetes: JACC state-of-the-art review. J Am Coll Cardiol. 2019;73(5):602\u201311.","journal-title":"J Am Coll Cardiol"},{"key":"2612_CR97","doi-asserted-by":"publisher","first-page":"101268","DOI":"10.1016\/j.arr.2021.101268","volume":"67","author":"AL Santos","year":"2021","unstructured":"Santos AL, Sinha S. Obesity and aging: molecular mechanisms and therapeutic approaches. Ageing Res Rev. 2021;67:101268.","journal-title":"Ageing Res Rev"},{"issue":"3","key":"2612_CR98","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1002\/ejhf.1614","volume":"22","author":"A Barandiaran Aizpurua","year":"2020","unstructured":"Barandiaran Aizpurua A, Sanders-van Wijk S, Brunner-La Rocca HP, Henkens M, Heymans S, Beussink-Nelson L, et al. Validation of the HFA-PEFF score for the diagnosis of heart failure with preserved ejection fraction. Eur J Heart Fail. 2020;22(3):413\u201321.","journal-title":"Eur J Heart Fail"},{"issue":"5","key":"2612_CR99","doi-asserted-by":"publisher","first-page":"e011366","DOI":"10.1161\/CIRCHEARTFAILURE.123.011366","volume":"17","author":"LB Kosyakovsky","year":"2024","unstructured":"Kosyakovsky LB, Liu EE, Wang JK, Myers L, Parekh JK, Knauss H, et al. Uncovering unrecognized heart failure with preserved ejection fraction among individuals with obesity and dyspnea. Circ Heart Fail. 2024;17(5):e011366.","journal-title":"Circ Heart Fail"},{"issue":"7","key":"2612_CR100","doi-asserted-by":"publisher","first-page":"1242","DOI":"10.1002\/ccd.30463","volume":"100","author":"JA Laukkanen","year":"2022","unstructured":"Laukkanen JA, Kunutsor SK, Hernesniemi J, Immonen J, Eskola M, Zaccardi F, et al. Underweight and obesity are related to higher mortality in patients undergoing coronary angiography: the KARDIO invasive cardiology register study. Catheter Cardiovasc Interv. 2022;100(7):1242\u201351.","journal-title":"Catheter Cardiovasc Interv"},{"issue":"7","key":"2612_CR101","doi-asserted-by":"publisher","first-page":"101040","DOI":"10.1016\/j.jacadv.2024.101040","volume":"3","author":"KC Bermea","year":"2024","unstructured":"Bermea KC, Lovell JP, Hays AG, Goerlich E, Vungarala S, Jani V, et al. A machine learning-derived score to effectively identify heart failure with preserved ejection fraction. JACC Adv. 2024;3(7):101040.","journal-title":"JACC Adv"}],"container-title":["Cardiovascular Diabetology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12933-025-02612-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12933-025-02612-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12933-025-02612-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,7]],"date-time":"2025-02-07T09:35:19Z","timestamp":1738920919000},"score":1,"resource":{"primary":{"URL":"https:\/\/cardiab.biomedcentral.com\/articles\/10.1186\/s12933-025-02612-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,7]]},"references-count":101,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["2612"],"URL":"https:\/\/doi.org\/10.1186\/s12933-025-02612-z","relation":{},"ISSN":["1475-2840"],"issn-type":[{"value":"1475-2840","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,7]]},"assertion":[{"value":"18 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The institution of Dr. De Boer has received research grants and\/or fees from Alnylam, AstraZeneca, Abbott, Bristol-Myers Squibb, Cardior Pharmaceuticals GmbH, NovoNordisk, and Roche; Dr. de Boer has had speaker engagements with and\/or received fees from and\/or served on an advisory board for Abbott, AstraZeneca, Bristol Myers Squibb, Cardior Pharmaceuticals GmbH, NovoNordisk, and Roche; Dr. de Boer received travel support from Abbott, Cardior Pharmaceuticals GmbH, and NovoNordisk. Dr Brugts reports speaker engagements and\/or advisory to Astra Zeneca, Abbott, Bayer, Boehringer Ingelheim, Novartis and Vifor outside the submitted work (3 year period). The institution of Dr. Van Dalen received research grants from Biotronik SE & Co. KG, Boehringer Ingelheim, Pfizer, Daiichi Sankyo, Sanofi and Novo Nordisk.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"71"}}